Triple class experience after initiation of combination antiretroviral treatment in Australia: survival and projections.

about

Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.

P2860

Q37086478-DDD0C11F-F297-4948-AFDD-E31E5D30EF7D

P2860

Triple class experience after initiation of combination antiretroviral treatment in Australia: survival and projections.

Item

http://www.wikidata.org/entity/Q35903886

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Triple class experience after ...... lia: survival and projections.

@ast

Triple class experience after ...... lia: survival and projections.

@en

type

Item

label

Triple class experience after ...... lia: survival and projections.

@ast

Triple class experience after ...... lia: survival and projections.

@en

prefLabel

Triple class experience after ...... lia: survival and projections.

@ast

Triple class experience after ...... lia: survival and projections.

@en

P1476

Triple class experience after ...... alia: survival and projections

@en

P2093

Darren B Russell

http://www.w3.org/2001/XMLSchema#string

John Chuah

http://www.w3.org/2001/XMLSchema#string

Kathy Petoumenos

http://www.w3.org/2001/XMLSchema#string

Peter Canavan

http://www.w3.org/2001/XMLSchema#string

Sadaf Marashi Pour

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV observational database.

Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study.

Adverse effects of antiretroviral therapy.

Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy.

Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment.

Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group.

Survivor treatment selection bias in observational studies: examples from the AIDS literature.

Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

P304

295-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1071/SH10008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ian J. Woolley

Matthew Law

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21851768

http://www.w3.org/2001/XMLSchema#string

P921

Australia

P932

3332145

http://www.w3.org/2001/XMLSchema#string

Triple class experience after initiation of combination antiretroviral treatment in Australia: survival and projections.

about

P2860

P2860

Triple class experience after initiation of combination antiretroviral treatment in Australia: survival and projections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932